1007-3418
2007 Issue 5
More studies on diagnostic pathology of liver diseases
WANG Tai-ling;LiU Xia;YOU Hong
WANG Tai-ling;LiU Xia;YOU Hong
..............page:321-322
Histopathological changes in livers of patients with chronic severe hepatitis B
ZHANG Li-jie;WANG Tai-ling;LIU Xu-hua;ZU Ke-jia;MENG Xin;WANG Yue;DUAN Zhong-ping
ZHANG Li-jie;WANG Tai-ling;LIU Xu-hua;ZU Ke-jia;MENG Xin;WANG Yue;DUAN Zhong-ping
..............page:323-325
Liver pathological changes and clinical features of patients with chronic hepatitis B virus infection in their immune tolerant phase and non-active status
LI Jia;ZHAO Gui-ming;ZHU Li-min;LI Ying;XIN Shao-jie
LI Jia;ZHAO Gui-ming;ZHU Li-min;LI Ying;XIN Shao-jie
..............page:326-329
A study on the hepatic histological changes and clinical manifestations in chronic HBV carriers
WEI Ni;YANG Dong;YANG Fang;WANG Ying;ZHAO Bing;L(U) Da-gang
WEI Ni;YANG Dong;YANG Fang;WANG Ying;ZHAO Bing;L(U) Da-gang
..............page:330-333
Liver histopathological features of chronic HBV carriers and inactive HBsAg carriers
FAN Hui-min;YANG Zhan;ZHANG Chun-lan;LI Wen-li
FAN Hui-min;YANG Zhan;ZHANG Chun-lan;LI Wen-li
..............page:334-337
The relationship between 31Pmagnetic resonance spectroscopy and the histopatllology of livers of chronic viral hepatitis patients
WU Bi;SONG Bin;ZHOU Xiang-ping;YANG Yang;LEI Xue-zhong;JIANG Li-li
WU Bi;SONG Bin;ZHOU Xiang-ping;YANG Yang;LEI Xue-zhong;JIANG Li-li
..............page:338-341
The degree of HBV suppression with 24 week telbivudine-or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52
JIA Ji-dong;HOU Jin-lin;YIN You-kuan;XU Dao-zhen;TAN De-ming;NIU Jun-qi;ZHOU Xia-qiu;WANG Yu-ming;ZHU Li-min;HE Yong-wen;REN Hong;WAN Mo-bin;CHEN Cheng-wei;WU Shan-ming;CHEN Ya-gang;XU Jia-zhang;WANG Qin-huan;WEI Lai;MA Hong
JIA Ji-dong;HOU Jin-lin;YIN You-kuan;XU Dao-zhen;TAN De-ming;NIU Jun-qi;ZHOU Xia-qiu;WANG Yu-ming;ZHU Li-min;HE Yong-wen;REN Hong;WAN Mo-bin;CHEN Cheng-wei;WU Shan-ming;CHEN Ya-gang;XU Jia-zhang;WANG Qin-huan;WEI Lai;MA Hong
..............page:342-345
Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients
LING Ning;ZHOU Zhi;ZHANG Da-zhi;REN Hong
LING Ning;ZHOU Zhi;ZHANG Da-zhi;REN Hong
..............page:346-349
The simultaneous knock-down of Ku70 and Ku80 by a tandem Ku-shRNA-encoding plasmid expression system
REN Jing-hua;LIN Ju-sheng;CHANG Ying;WU Ying;ZHANG Ying-hui;ZHANG Qiang;HE Xing-xing
REN Jing-hua;LIN Ju-sheng;CHANG Ying;WU Ying;ZHANG Ying-hui;ZHANG Qiang;HE Xing-xing
..............page:350-353
Changes of Toll-like receptor(TLR)2 and TLR4 on the peripheral blood mononuclear cells in patients with chronic hepatitis Band chronic severe hepatitis B
WEI Xiu-qing;WEN Zhuo-fu;ZHENG Feng-ping;YAO Ji-lu
WEI Xiu-qing;WEN Zhuo-fu;ZHENG Feng-ping;YAO Ji-lu
..............page:354-357
Evaluation of interventional therapy for hepatocellular carcinoma with arteriovenous fistulas:an analysis of 38 cases
LUO Xiao-ping;GAN Wei
LUO Xiao-ping;GAN Wei
..............page:358-361
Heat-shock protein 27 linked to multi-drug resistance in human hepatic cancer cell lines
PENG Shi-fang;FU Lei;TAN De-ming
PENG Shi-fang;FU Lei;TAN De-ming
..............page:362-365
The expression of peroxiredoxin Ⅱ in hepatocellular carcinoma and its significance
YUE Hai-ying;CAO Ji;CUI Jie-feng;DAI Zhi;SU Jian-jia;DUAN Xiao-xian;YANG Chun;YUE Hui-fen;LI Yuan;LIU Yin-kun
YUE Hai-ying;CAO Ji;CUI Jie-feng;DAI Zhi;SU Jian-jia;DUAN Xiao-xian;YANG Chun;YUE Hui-fen;LI Yuan;LIU Yin-kun
..............page:366-369
A clinicopathological analysis of liver retransplantation in 22 cases
SHAO Chun-kui;ZHOU Jing;FENG Zhi-ying;CHEN Gui-hua
SHAO Chun-kui;ZHOU Jing;FENG Zhi-ying;CHEN Gui-hua
..............page:370-373
Liver pathology in idiopathic portal hypertension
LIU Xia;WANG Tai-ling;XIANG Can-hong;PENG Xiang-xin;WANG Yue;CHEN Nian;ZHANG Min
LIU Xia;WANG Tai-ling;XIANG Can-hong;PENG Xiang-xin;WANG Yue;CHEN Nian;ZHANG Min
..............page:374-377
Intrasplenic transplantation of newborn rat hepatocytes with rALR for treating rats with acute hepatic failure
CHEN Yao;YUAN Gang;Sun Hang;LIU Qi
CHEN Yao;YUAN Gang;Sun Hang;LIU Qi
..............page:378-382
..............page:383-384
..............page:385-386
The effects of Variations of HBVS gene on its RNA secondary structure in serious hepatitis B patients
LI Jun-qiang;XU Zheng-ju;LIU Feng;DU shao-cai
LI Jun-qiang;XU Zheng-ju;LIU Feng;DU shao-cai
..............page:387-388
The expression of cannabinoid receptor 1 in fibrotic liver tissues of mice infested with Schistosoma mamsoni
GAO Xiao;GUO YAN;LIU Hong-yan;TANG Wang-xian
GAO Xiao;GUO YAN;LIU Hong-yan;TANG Wang-xian
..............page:389-390
A study on inhibiting hepatocellular carcinoma invasion with c-met-siRNA induced by retrovirus in vivo
XIE Bin;DONG Jia-hong
XIE Bin;DONG Jia-hong
..............page:391-392
Systemic inflammatory response syndrome and related inflammatory mediators in severe viral hepatitis
JIE Sheng-hua;LI Hui-yu;ZHU Xiang-zhen
JIE Sheng-hua;LI Hui-yu;ZHU Xiang-zhen
..............page:392-393
Effects of rat recombinant leptin on gene expression of collagen I and tissue inhibitor of metalloproteinase 1 in HSC-T6 cells
WANG Li-ting;MA Hong;ZHANG Peng;JIA ji-dong
WANG Li-ting;MA Hong;ZHANG Peng;JIA ji-dong
..............page:394-395
Progress in the study of recurrent primary biliary cirrhosis after orthotopic liver transplantation
ZHAO Peng;ZHU Liang;YAO Ding-kang
ZHAO Peng;ZHU Liang;YAO Ding-kang
..............page:396-398
Natural killer T cells and liver diseases
XU Cheng-fu;LI You-ming
XU Cheng-fu;LI You-ming
..............page:399-400
..............page:329,333,337,384
..............page:373